​

Sonnet BioTherapeutics Ownership | Who Owns Sonnet BioTherapeutics?

OverviewForecastFinancialsChart

Sonnet BioTherapeutics Ownership Summary

Sonnet BioTherapeutics is owned by 610.28% institutional investors, 4.25% insiders. Geode capital management is the largest institutional shareholder, holding 0% of SONN shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.45% of its assets in Sonnet BioTherapeutics shares.

SONN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSonnet BioTherapeutics610.28%4.25%-514.52%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Geode capital management---
Investment house---
Golden state wealth management---
Carolina wealth advisors---
Jane street group---
State street---
Jpmorgan chase---
Ubs group---
Hrt financial lp---
Larson financial group---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Geode capital management---
Investment house---
Golden state wealth management---
Carolina wealth advisors---
Jane street group---
State street---
Jpmorgan chase---
Ubs group---
Hrt financial lp---
Larson financial group---

Top Buyers

HolderShares% AssetsChange
Carolina wealth advisors---32.00
Citigroup---134.00
Golden state wealth management---202.00
Ubs group---277.00
Larson financial group---4.30K

Top Sellers

HolderShares% AssetsChange
Vanguard group---96.38K
Hrt financial lp---74.27K
Geode capital management---61.84K
Goldman sachs group---55.13K
Bit capital gmbh---48.36K

Sold Out

HolderChange
Carolina wealth advisors-32.00
Citigroup-134.00
Golden state wealth management-202.00
Ubs group-277.00
Larson financial group-4.30K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202529222.22%24,198,79413313.52%6102948.22%26420.00%2100.00%
Jun 30, 2025928.57%180,40611.88%426.91%525.00%1-
Mar 31, 20257-22.22%161,24681.03%421.21%4-55.56%1-
Dec 31, 20249-89,070-4-9---
Sep 30, 20221-94.44%2,000-99.94%-0.00%--100.00%--100.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr28.10K0.45%26.26K
Fidelity Extended Market Index19.79K0.29%-139.00
Cinvest Azero Global FI7.10K0.10%2.42K
Fidelity Total Market Index6.32K0.09%4.90K
Fidelity Series Total Market Index3.34K0.05%-
Spartan Total Market Index Pool G1.89K0.03%1.69K
Northern Trust Extended Eq Market Idx92.000.00%-
NT Ext Equity Mkt Idx Fd - L92.000.00%-
Spartan Extended Market Index Pool F139.000.00%139.00
Spartan Extended Market Index Pool E57.000.00%-

Recent Insider Transactions

DateNameRoleActivityValue
Oct 27, 2023Rao Raghu-Buy$25.00K
Oct 27, 2023Rao Raghu-Buy$50.00K
Oct 27, 2023Mohan Pankaj Chairman, President and CEOBuy$110.00K
Oct 27, 2023Mohan Pankaj Chairman, President and CEOBuy$55.00K
Jun 14, 2023Dexter Susan Chief Technical OfficerBuy$7.00K

Insider Transactions Trends

DateBuySell
2025 Q4--
2025 Q3--
2025 Q2--
2025 Q1--
2023 Q44-

SONN Ownership FAQ

Who Owns Sonnet BioTherapeutics?

Sonnet BioTherapeutics shareholders are primarily institutional investors at 610.28%, followed by 4.25% insiders and -514.53% retail investors. The average institutional ownership in Sonnet BioTherapeutics's industry, Biotech Stocks , is 381.47%, which Sonnet BioTherapeutics exceeds.

Who owns the most shares of Sonnet BioTherapeutics?

Sonnet BioTherapeutics’s largest shareholders are Geode capital management (0 shares, 0%), Investment house (0 shares, 0%), and Golden state wealth management (0 shares, 0%). Together, they hold 0% of Sonnet BioTherapeutics’s total shares outstanding.

Does Blackrock own Sonnet BioTherapeutics?

BlackRock is not among the top 10 institutional shareholders of Sonnet BioTherapeutics.

Who is Sonnet BioTherapeutics’s biggest shareholder by percentage of total assets invested?

Geode capital management is Sonnet BioTherapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Sonnet BioTherapeutics shares, valued at 0$.

Who is the top mutual fund holder of Sonnet BioTherapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Sonnet BioTherapeutics shares, with 0.45% of its total shares outstanding invested in 28.1K Sonnet BioTherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools